Does TEBENTAFUSP-TEBN Cause Malignant neoplasm progression? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Malignant neoplasm progression have been filed in association with TEBENTAFUSP-TEBN. This represents 9.1% of all adverse event reports for TEBENTAFUSP-TEBN.
32
Reports of Malignant neoplasm progression with TEBENTAFUSP-TEBN
9.1%
of all TEBENTAFUSP-TEBN reports
3
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TEBENTAFUSP-TEBN?
Of the 32 reports, 3 (9.4%) resulted in death, 4 (12.5%) required hospitalization, and 1 (3.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEBENTAFUSP-TEBN. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does TEBENTAFUSP-TEBN Cause?
Pyrexia (63)
Cytokine release syndrome (59)
Hypotension (47)
Rash (43)
Disease progression (42)
Chills (38)
Product dose omission issue (37)
Nausea (29)
Vomiting (22)
Pruritus (21)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TEBENTAFUSP-TEBN Alternatives Have Lower Malignant neoplasm progression Risk?
TEBENTAFUSP-TEBN vs TECFIDERA
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M MEDRONATE
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M OXIDRONATE
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M PERTECHNETATE